Expert consensus on the whole-process management of neovascular glaucoma associated with diabetic retinopathy
10.13389/j.cnki.rao.2025.0159
- VernacularTitle:糖尿病视网膜病变相关新生血管性青光眼全流程管理专家共识
- Author:
Haiyan WANG
;
Xi SHEN
;
Junyi CHEN
;
Kun LIU
- Collective Name:Ophthalmology and Visual Science Professional Committee of Chinese Research Hospital Association
- Publication Type:Journal Article
- Keywords:
diabetic retinopathy;
neovascular glaucoma;
anti-VEGF drugs;
pan-retinalphotocoagulation;
prevention and control;
expert consensus
- From:
Recent Advances in Ophthalmology
2025;45(12):925-929
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic retinopathy(DR)-related neovascular glaucoma(NVG)is a severe ocular complication of diabe-tes,characterized by a high blindness rate and complex diagnosis and treatment.Currently,there is a lack of systematic,whole-process management guidelines for DR-NVG in China.To standardize the clinical diagnosis,treatment,and health management of DR-NVG,domestic retinal disease and glaucoma experts have developed the first expert consensus on the whole-process management of neovascular glaucoma associated with diabetic retinopathy,by integrating the latest evi-dence-based medical evidence and clinical practice experience from both domestic and intemational sources.Centering on the disease characteristics of DR-NVG,this consensus proposes scientific and standardized whole-process management strategies,encompassing early screening and risk assessment,precise diagnosis and staging,multi-mode combination ther-apy,perioperative management,and long-term follow-up.It mainly covers the screening and diagnosis of high-risk popula-tions,the timing of anti-VEGF therapy and pan-retinal photocoagulation application,and indications for surgical interven-tion.The aim is to provide standardized guidance for ophthalmologists and public health workers,improve the prevention and treatment level of DR-NVG,and reduce the incidence of irreversible visual impairment.
